ISSN: 2165-7904

Revista de terapia de pérdida de peso y obesidad

Acceso abierto

Nuestro grupo organiza más de 3000 Series de conferencias Eventos cada año en EE. UU., Europa y América. Asia con el apoyo de 1.000 sociedades científicas más y publica más de 700 Acceso abierto Revistas que contienen más de 50.000 personalidades eminentes, científicos de renombre como miembros del consejo editorial.

Revistas de acceso abierto que ganan más lectores y citas
700 revistas y 15 000 000 de lectores Cada revista obtiene más de 25 000 lectores

Indexado en
  • Índice Copérnico
  • Google Académico
  • Abrir puerta J
  • Revista GenámicaBuscar
  • Centro Internacional de Agricultura y Biociencias (CABI)
  • Búsqueda de referencia
  • Universidad Hamdard
  • EBSCO AZ
  • OCLC-WorldCat
  • Catálogo en línea SWB
  • CABI texto completo
  • cabina directa
  • publones
  • Fundación de Ginebra para la educación y la investigación médicas
  • Pub Europeo
  • Universidad de Bristol
  • publicado
  • ICMJE
Comparte esta página

Abstracto

Analysis for the Success Rate of Patients after Laparoscopic Sleeve Gastrectomy

Jose Baptista*, Vanessa Praxedes, Ana André, Edgar Rosa, Carlos Trindade and Luis Cortez

Background: Success rate of laparoscopic sleeve gastrectomy (SG) depends on disease and patient characteristics that are yet to be fully established.
Objectives: To evaluate which patient characteristics influence the success of SG.
Setting: National bariatric reference centre at a Public Hospital.
Methods: A retrospective study was performed based on prospectively collected data of patients who had bariatric surgery at our institution, during a 5 year period. Patients with 12 or more months of follow-up were included. We analyzed data from 133 SG. Seventy-nine percent of the patients were female with a median age of 46 years, a median baseline Body Mass Index (BMI) of 41 kg/m2 and a mean of 2.5 out of 7 comorbidities.
Results: After the first year, the mean percentage Excess Weight Loss (%EWL) was 69.3%, the mean change in BMI was -11.8 kg/m2 and the mean % total body weight loss was 27.4%. Surgical success (%EWL ≥ 50%) was achieved in 82% of the patients, with significant improvement or resolution of comorbidities (follow-up rate 76%-88%). We found statistical significant differences with baseline BMI (p<0.0001), with OSA (p<0.0001), with age (p=0.04) and with the number of comorbidities (p=0.05). Higher baseline characteristics implicated less %EWL. The presence of HTN or arthropathy and being a volume eater or a sweet eater did not influence surgical success (χ2 ≤ 0.01).
Conclusions: SG is an effective surgical treatment for obesity. After one year the majority of patients had surgical success and major comorbidities were mitigated or resolved. Success was influenced by specific patient and disease characteristics.